Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Apremilast may help treat hair loss in alopecia areata.

Minoxidil effectively promotes hair growth in seborrheic alopecia.

Electrical stimulation with minoxidil boosts hair cell growth.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Sodium valproate reduced seizures in many patients with resistant epilepsy.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

A new method using nanolipogels with fucosterol can help regrow hair by targeting follicles, reducing inflammation, and improving blood flow.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Preservative-free latanoprost effectively lowers eye pressure with fewer side effects.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The new 5% minoxidil formulation without propylene glycol effectively promotes hair growth with fewer side effects and better user satisfaction.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.